Übersicht			Auf mobile öffnen

Lieferstatus:	Auf Bestellung (Lieferzeit unbekannt)
Veröffentlichung:	Dezember 2017
Genre:	Naturwissensch., Medizin, Technik
	B / Biomedical and Life Sciences / Biomedical Research / Cancer Research
ISBN:	9783319701417
EAN-Code:	9783319701417
Verlag:	Springer Nature EN
Einband:	Gebunden
Sprache:	English
Serie:	#16 - Resistance to Targeted Anti-Cancer Therapeutics
Dimensionen:	H 235 mm / B 155 mm / D
Gewicht:	471 gr
Seiten:	184
Illustration:	XV, 184 p. 12 illus., schwarz-weiss Illustrationen
Bewertung:	Titel bewerten / Meinung schreiben

Inhalt:

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.